Skip to main content
Clinical Trials/NCT02411279
NCT02411279
Unknown
Not Applicable

Anticipation and Detection of Heart Failure Decompensation With Automatic Treatment of Informations Derived From Non Intrusive Sensors and Devices

University Hospital, Strasbourg, France1 site in 1 country20 target enrollmentJune 2015
ConditionsHeart Failure

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heart Failure
Sponsor
University Hospital, Strasbourg, France
Enrollment
20
Locations
1
Primary Endpoint
Anticipation and detection of heart failure with automatic treatment of information derived from non intrusive sensors and devices
Last Updated
8 years ago

Overview

Brief Summary

Heart failure (HF) is a serious chronic disease with frequent readmissions, some of which can be prevented by early action. The management of HF is complex: long, often difficult and costly. In France, nearly one million people suffer from HF and 120,000 new cases are diagnosed every year. With the aging population, this number will continue to evolve and become a real public health problem. Within 10 to 20 years ahead, WHO projects that heart failure in either the 3 most common diseases in industrialized countries.

The objective of the project is to test an intelligent platform for monitoring at home, using non-intrusive sensors, patients with heart failure, particularly those with stage II and III NYHA. It will assist the medical automating the processing of information from these sensors to detect and report an early stage risk situations.

Patient monitoring, by a system of telemedicine tools associated with motivation and education helps significantly reduce the number of days of hospitalization becomes important when the patient is hospitalized for acute HF.

Registry
clinicaltrials.gov
Start Date
June 2015
End Date
September 2017
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Strasbourg, France
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Population with heart failure stage II and III

Exclusion Criteria

  • Population whose age is less than 18 years

Outcomes

Primary Outcomes

Anticipation and detection of heart failure with automatic treatment of information derived from non intrusive sensors and devices

Time Frame: patient's medical data will be controlled remotely by health professional for the duration of hospital stay, up to 1 year]

Study Sites (1)

Loading locations...

Similar Trials